Knight Therapeutics, Inc. (GUD.TO)
12.06
+0.01
(+0.08%)
CAD |
TSX |
Nov 13, 16:00
Knight Therapeutics Net Income (Quarterly) : -2.68M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -2.68M |
| June 30, 2026 | -3.361M |
| March 31, 2026 | 13.17M |
| December 31, 2025 | 8.854M |
| September 30, 2025 | -3.791M |
| June 30, 2025 | -12.62M |
| March 31, 2025 | 2.185M |
| December 31, 2024 | 10.74M |
| September 30, 2024 | 0.085M |
| June 30, 2024 | -1.942M |
| March 31, 2024 | -4.546M |
| December 31, 2023 | -24.33M |
| September 30, 2023 | 9.588M |
| June 30, 2023 | 1.84M |
| March 31, 2023 | -3.937M |
| December 31, 2022 | -15.19M |
| September 30, 2022 | 1.591M |
| June 30, 2022 | 2.516M |
| March 31, 2022 | -18.81M |
| December 31, 2021 | -8.301M |
| September 30, 2021 | -8.586M |
| June 30, 2021 | 29.00M |
| March 31, 2021 | 3.558M |
| December 31, 2020 | 8.233M |
| September 30, 2020 | 17.49M |
| Date | Value |
|---|---|
| June 30, 2020 | 15.51M |
| March 31, 2020 | -9.477M |
| December 31, 2019 | -3.153M |
| September 30, 2019 | -2.959M |
| June 30, 2019 | 18.96M |
| March 31, 2019 | 5.189M |
| December 31, 2018 | 0.221M |
| September 30, 2018 | 12.93M |
| June 30, 2018 | 4.019M |
| March 31, 2018 | 6.909M |
| December 31, 2017 | 7.145M |
| September 30, 2017 | 3.593M |
| June 30, 2017 | 0.459M |
| March 31, 2017 | 6.047M |
| December 31, 2016 | 7.939M |
| September 30, 2016 | 5.698M |
| June 30, 2016 | 4.446M |
| March 31, 2016 | 0.477M |
| December 31, 2015 | 5.554M |
| September 30, 2015 | 6.277M |
| June 30, 2015 | 8.520M |
| March 31, 2015 | 13.82M |
| December 31, 2014 | 124.98M |
| September 30, 2014 | 0.5626M |
| June 30, 2014 | 0.3906M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| HLS Therapeutics, Inc. | -3.116M |
| Bausch Health Cos., Inc. | 624.37M |
| Cipher Pharmaceuticals, Inc. | 15.25M |
| BioSyent, Inc. | 2.849M |
| Revive Therapeutics Ltd. | 0.0033M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 137.69M |
| Total Expenses (Quarterly) | 140.37M |
| EPS Diluted (Quarterly) | -0.0273 |
| Enterprise Value | 1.082B |
| Gross Profit Margin (Quarterly) | 38.94% |
| Profit Margin (Quarterly) | -1.95% |
| Earnings Yield | 1.33% |
| Operating Earnings Yield | 2.63% |
| Normalized Earnings Yield | 2.090 |